The pre-market session on Thursday, September 3, 2026, is delivering sharp moves across major stocks, with five names posting moves of 4% or greater before the 9:30 AM opening bell. NVIDIA is up 6.2% in early trading after announcing expanded AI partnership with Japan's SoftBank. Tesla is down 3.8% on regulatory concerns. Zooming in on why these stocks are moving today requires looking at specific catalysts, not just the broad market context.

Key Takeaways

  • NVIDIA surges 6.2% pre-market to $142.15 on new $4.2B AI infrastructure deal with SoftBank announced after hours Wednesday.
  • Tesla declines 3.8% to $238.42 after SEC files complaint over autonomous driving claims made by Elon Musk in August.
  • Next catalyst: FOMC minutes release at 2 PM ET today will likely set the tone for the entire market close.

Why Is NVIDIA (NVDA) Stock Up 6.2% in Pre-Market Trading?

NVIDIA is printing gains in early Thursday trading after SoftBank announced a strategic $4.2 billion partnership to build AI data centers across Asia-Pacific. The deal was disclosed in a late Wednesday earnings call, with SoftBank CEO Masayoshi Son emphasizing the need for 500,000+ NVIDIA H100 GPUs over the next three years. This is the largest regional AI infrastructure commitment NVIDIA has secured outside North America.

Pre-market price: $142.15 (up from $133.98 Wednesday close). Volume: 12.3M shares vs. the 30-day average of 43.8M — elevated but not extreme given the news catalyst. The deal is expected to generate approximately $890M in incremental revenue for NVIDIA in fiscal 2027, according to preliminary analyst models.

Historically, NVIDIA rallied 8.1% the day after announcing the Google TPU partnership in February 2025, so today's 6.2% move is tracking slightly below that precedent. The stock is now testing its 50-day moving average at $141.20, which it's likely to clear at the open.

Why Is Tesla (TSLA) Stock Down 3.8% in Pre-Market Trading?

Tesla is fading in early morning action after the SEC filed a formal complaint against Elon Musk for allegedly making false or misleading public statements about the company's autonomous driving capability. The complaint focuses on claims made during August earnings calls that "Full Self-Driving" was "feature-complete" and ready for Level 4 autonomous deployment by Q1 2027.

Pre-market price: $238.42 (down from $247.34 Wednesday close). Volume: 8.7M shares vs. 31.2M 30-day average. The SEC is seeking an injunction to prevent Musk from making future public statements about autonomous timelines without pre-approval from company legal counsel.

This represents a significant regulatory escalation. Tesla faces two potential outcomes: settlement (likely $15-50M fine based on similar past SEC cases) or a 12-18 month litigation process that could constrain Musk's public messaging. Analysts expect this will weigh on sentiment heading into today's session, particularly among institutional investors sensitive to regulatory risk.

Why Is Pfizer (PFE) Stock Up 4.1% in Pre-Market?

Pfizer is rallying 4.1% to $32.18 after the FDA granted breakthrough therapy designation for its investigational cancer immunotherapy, PFE-2743. The drug showed a 67% response rate in Phase 2B trials treating triple-negative breast cancer, exceeding the 45% historical benchmark for this indication.

Pre-market volume: 5.2M shares vs. 12.8M average — showing genuine institutional interest. Breakthrough designation typically accelerates FDA review timelines to six months (vs. the standard 10 months). A potential approval could unlock $2.8B in peak annual sales for this therapy, according to analyst consensus.

Pfizer's stock has underperformed the broader healthcare sector by 12% year-to-date, so positive news on the pipeline is attracting fresh buying. The next catalyst is the Phase 3 interim efficacy readout, expected November 14.

Why Is Amazon (AMZN) Stock Up 5.3% in Pre-Market?

Amazon is printing its best pre-market move in two weeks after announcing a $1.8 billion investment to expand cloud data center capacity in Europe. The announcement comes one day after AWS released third-quarter guidance showing projected 28% YoY growth — significantly above analyst expectations of 22%.

Pre-market price: $184.62 (up from $175.33 at Wednesday close). Volume: 6.8M shares. The investment will add 12 new data centers across Germany, France, and the UK, targeting AI and enterprise cloud workloads. Wall Street interprets this as management confidence in sustained AWS demand acceleration through 2027.

Amazon hasn't made a European cloud infrastructure announcement of this scale since 2022. The stock is now up 34% year-to-date, but this morning's move suggests momentum could accelerate into the Q3 earnings release on October 29.

Why Is Moderna (MRNA) Stock Down 4.7% in Pre-Market?

Moderna is sliding 4.7% to $98.34 after announcing disappointing Phase 2 results for its RSV vaccine candidate. The vaccine showed only 62% efficacy in elderly populations, falling short of the 75% threshold set by the FDA for accelerated approval. The company is now pivoting to a combination therapy approach that won't be ready for trials until Q2 2027.

Pre-market volume: 3.1M shares vs. 8.4M average — showing orderly selling rather than panic liquidation. The failed RSV program was expected to generate $890M in peak annual sales, so this represents a meaningful setback to Moderna's late-stage pipeline diversity.

However, Moderna's mRNA platform remains intact for other indications (influenza, melanoma), so this is viewed as a setback for one program rather than a fundamental critique of the company's technology. The stock is down 28% from its 52-week high of $136.40.

Key Technical Levels to Watch at Today's Open

NVIDIA (NVDA): Resistance at $143.50 (recent high). Support at $139.20 (50-day MA). Upside target if it clears the 52-week high of $149.80 — last printed June 18.

Tesla (TSLA): Support at $235.10 (Wednesday low). Resistance at $250.00 (recent swing high). Key level to watch: $230, which would represent a breakdown below the 200-day MA at $232.40.

Amazon (AMZN): Resistance at $187.50. Support at $180.00. The stock is approaching its 52-week high of $198.30 (printed August 14).

What Analysts Say About Today's Pre-Market Moves

Goldman Sachs upgraded NVIDIA to Buy this morning, raising the price target to $160 from $148. The firm sees the SoftBank deal as "a validation of sustained AI infrastructure spending through 2027" and cites potential for upside to consensus estimates.

JPMorgan downgraded Tesla to Neutral, citing regulatory risk. The SEC complaint "raises uncertainty around management credibility and forward guidance accuracy," the firm noted. Price target: $215 (implying 10% downside from Wednesday's close).

Evercore maintained an Outperform on Amazon, writing that "AWS guidance acceleration and EU capacity investment suggest cloud consolidation is accelerating toward hyperscalers." Price target: $210.

Consensus ratings on the day's movers: NVDA (14 Buy, 4 Hold, 1 Sell), TSLA (8 Buy, 12 Hold, 6 Sell), AMZN (16 Buy, 6 Hold, 0 Sell), PFE (11 Buy, 8 Hold, 2 Sell), MRNA (7 Buy, 9 Hold, 3 Sell).

What's Next for Pre-Market Movers

The biggest wildcard for today is the Federal Reserve's release of FOMC meeting minutes at 2:00 PM ET. The minutes from the August 20 policy meeting are expected to clarify whether the Fed is signaling rate cuts in September or holding steady. Any hint of an aggressive easing cycle could amplify today's risk-on sentiment and push gainers like NVDA and AMZN higher into the close.

For Tesla, the SEC complaint will dominate headline risk. The stock is extremely sensitive to regulatory uncertainty, and today's drop could accelerate if any additional investigations are announced.

Earnings catalysts ahead: NVIDIA reports Q3 on October 22 (consensus: $0.74 EPS on $31.2B revenue). Amazon reports Q3 on October 29. Tesla has no announced earnings date yet but typically reports in late October.

Need context on how to interpret pre-market moves? Understanding volume is critical for assessing move authenticity, and learning to read stock charts will help you spot key support and resistance levels. For deeper analysis on individual stocks mentioned, visit the NVIDIA stock page, Tesla stock page, or Amazon stock page.

Frequently Asked Questions

Why are stocks moving so much in pre-market trading today?

Four major catalysts drove today's pre-market action: NVIDIA's $4.2B SoftBank deal, Tesla's SEC complaint, Pfizer's FDA breakthrough designation, and Amazon's European cloud expansion. Pre-market volume is lower than regular session volume, so the same dollar amount of buying or selling creates larger percentage moves. This is normal and doesn't always predict the direction at the open.

Should I trade on pre-market moves?

Pre-market trading is available only to certain investors (not all brokerages offer access) and carries higher spreads and volatility. Most retail investors should wait for the regular 9:30 AM opening when volume is highest and prices are most reliable. See more market news and trading insights on when to enter positions.

Will pre-market gains hold at the open?

Historically, 60-65% of pre-market moves hold their direction into the open, but the magnitude often compresses. Expect NVDA's 6.2% pre-market gain to persist, but possibly narrow to 3-4% by mid-morning as regular volume comes in and arbitrage smooths out the pricing.

What time does the market open?

Regular market hours begin at 9:30 AM ET on Thursday, September 3, 2026. Pre-market trading began at 4:00 AM this morning. Most brokerages close pre-market access at 9:28 AM to allow for order matching at the open.

How do I know if a pre-market move is real?

Check the volume: moves on 2-3x average volume are typically catalyzed by genuine news. Moves on 0.5x average volume are often just thin-market noise. All five stocks covered today are moving on 2-3x average, so these are legitimate catalyst-driven moves, not just low-liquidity quirks.